4.6 Article

The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Soluble CD36 (sCD36) Clusters with Markers of Insulin Resistance, and High sCD36 Is Associated with Increased Type 2 Diabetes Risk

A. Handberg et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)

Article Biochemical Research Methods

Discovery of Antagonists for Human Scavenger Receptor CD36 via an ELISA-Like High-Throughput Screening Assay

Li Wang et al.

JOURNAL OF BIOMOLECULAR SCREENING (2010)

Article Biochemistry & Molecular Biology

Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose tolerance

Jose-Manuel Fernandez-Real et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)

Article Multidisciplinary Sciences

Soluble CD36 Ectodomain Binds Negatively Charged Diacylglycerol Ligands and Acts as a Co-Receptor for TLR2

Maximiliano J. Jimenez-Dalmaroni et al.

PLOS ONE (2009)

Article Endocrinology & Metabolism

Soluble insulin receptor ectodomain is elevated in the plasma of patients with diabetes

Toshiyuki Obata et al.

DIABETES (2007)

Review Biochemistry & Molecular Biology

CD36: Implications in cardiovascular disease

Maria Febbraio et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)

Article Biochemical Research Methods

Preparation and characterization of MAbs against different epitopes of CD226 (PTA1)

W Jia et al.

HYBRIDOMA (2000)

Article Biochemistry & Molecular Biology

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

B Jimenez et al.

NATURE MEDICINE (2000)